Gregory T. Maclennan

Gregory T. Maclennan's AcademicInfluence.com Rankings

Engineering

#7165

World Rank

#8528

Historical Rank

Biomedical Engineering

#695

World Rank

#707

Historical Rank

engineering Degrees

Gregory T. Maclennan

Philosophy

#9545

World Rank

#13122

Historical Rank

Logic

#6519

World Rank

#8043

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Why Is Gregory T. Maclennan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gregory T. Maclennan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

TNM staging of renal cell carcinoma (1997) (451)
Activation of PI3K‐Akt signaling pathway promotes prostate cancer cell invasion (2007) (294)
Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter? (2002) (275)
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine (2017) (268)
Clear Cell Papillary Renal Cell Carcinoma: A Distinct Histopathologic and Molecular Genetic Entity (2008) (257)
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia (2007) (256)
Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. (2004) (233)
Molecular pathology of lung cancer: key to personalized medicine (2012) (225)
Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. (1997) (210)
Union Internationale Contre le Cancer (UICC) and the American Joint TNM Staging of Renal Cell Committee on Cancer (AJCC) Carcinoma (1997) (198)
Small cell carcinoma of the urinary bladder (2004) (196)
Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen‐independent status (2004) (186)
Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. (2005) (183)
Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. (1997) (182)
Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. (2004) (180)
Bladder cancer: translating molecular genetic insights into clinical practice. (2011) (178)
Tubulocystic Carcinoma of the Kidney: Clinicopathologic Analysis of 31 Cases of a Distinctive Rare Subtype of Renal Cell Carcinoma (2009) (178)
The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study. (2006) (171)
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. (1996) (164)
Molecular Evidence Supporting Field Effect in Urothelial Carcinogenesis (2005) (164)
TFE3 Break-apart FISH Has a Higher Sensitivity for Xp11.2 Translocation–associated Renal Cell Carcinoma Compared With TFE3 or Cathepsin K Immunohistochemical Staining Alone: Expanding the Morphologic Spectrum (2013) (147)
Histologic grading of noninvasive papillary urothelial neoplasms. (2007) (146)
Evidence for common clonal origin of multifocal lung cancers. (2009) (145)
Microvessel density in renal cell carcinoma: lack of prognostic significance. (1995) (137)
Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway. (2014) (136)
Analysis of the molecular quality of human tissues: an experience from the Cooperative Human Tissue Network. (2002) (134)
Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. (2003) (134)
Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. (2005) (128)
ERG–TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin (2011) (124)
Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation. (2002) (118)
Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation (2005) (117)
Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. (2009) (116)
Sarcomatoid Carcinoma of the Urinary Bladder: The Final Common Pathway of Urothelial Carcinoma Dedifferentiation (2011) (114)
Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. (2007) (114)
Chemoprevention of prostate carcinogenesis by α-difluoromethylornithine in TRAMP mice (2000) (114)
Expression of S100 protein family members in the pathogenesis of bladder tumors. (2007) (110)
Constitutive activation of PI3K‐Akt and NF‐κB during prostate cancer progression in autochthonous transgenic mouse model (2005) (105)
Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans. (1999) (105)
Experimental rodent models of prostatitis: limitations and potential (2007) (103)
Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma (2010) (100)
Molecular genetic alterations in the laser‐capture–microdissected stroma adjacent to bladder carcinoma (2003) (100)
Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. (2000) (99)
Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray (2004) (96)
Renal Cell Carcinomas With Papillary Architecture and Clear Cell Components: The Utility of Immunohistochemical and Cytogenetical Analyses in Differential Diagnosis (2008) (96)
Up‐regulation of insulin‐like growth factor binding protein‐3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice (2005) (91)
Molecular Genetic Evidence for the Independent Origin of Multifocal Papillary Tumors in Patients with Papillary Renal Cell Carcinomas (2005) (89)
Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. (2007) (87)
Soft tissue tumors of the urinary bladder Part II: malignant neoplasms. (2007) (84)
Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder (2006) (84)
Small cell carcinoma of the urinary bladder. (2010) (81)
Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors. (2008) (81)
Inflammatory myofibroblastic tumors of the genitourinary tract--single entity or continuum? (2008) (79)
Epidermal Growth Factor Receptor Protein Expression and Gene Amplification in Small Cell Carcinoma of the Urinary Bladder (2007) (79)
Molecular Genetic Evidence for Different Clonal Origin of Components of Human Renal Angiomyolipomas (2001) (77)
c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications (2005) (76)
Histologic grading of urothelial carcinoma: a reappraisal. (2012) (76)
Lymphoepithelioma-like Carcinoma of the Urinary Bladder: Clinicopathologic, Immunohistochemical, and Molecular Features (2011) (74)
TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder (2009) (73)
Histogenesis of Clear Cell Adenocarcinoma in the Urinary Tract: Evidence of Urothelial Origin (2008) (72)
Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor (2002) (72)
The S100 proteins for screening and prognostic grading of bladder cancer. (2007) (72)
The origins of urothelial carcinoma (2010) (71)
p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma (2012) (70)
Urothelial Carcinoma With an Inverted Growth Pattern Can be Distinguished From Inverted Papilloma by Fluorescence In Situ Hybridization, Immunohistochemistry, and Morphologic Analysis (2007) (70)
Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer. (1998) (69)
Malignant Perivascular Epithelioid Cell Neoplasm (PEComa) of the Urinary Bladder With TFE3 Gene Rearrangement: Clinicopathologic, Immunohistochemical, and Molecular Features (2013) (69)
Protection against oxidative DNA damage and stress in human prostate by glutathione S‐transferase P1 (2014) (68)
Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder (2004) (68)
Laser-assisted Microdissection in Translational Research: Theory, Technical Considerations, and Future Applications (2012) (67)
Natural history of urothelial inverted papilloma (2006) (66)
Interphase Fluorescence In situ Hybridization Analysis of Chromosome 12p Abnormalities Is Useful for Distinguishing Epidermoid Cysts of the Testis from Pure Mature Teratoma (2006) (66)
Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice (2015) (65)
Telomere Shortening and Chromosomal Abnormalities in Intestinal Metaplasia of the Urinary Bladder (2007) (64)
Deregulation of FOXO3A during prostate cancer progression. (2009) (63)
Metabolic Syndrome, Inflammation and Lower Urinary Tract Symptoms – Possible Translational Links (2015) (62)
Apigenin blocks IKKα activation and suppresses prostate cancer progression (2015) (61)
Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors. (2005) (61)
Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer (2014) (60)
Multilocular Cystic Renal Cell Carcinoma: Similarities and Differences in Immunoprofile Compared With Clear Cell Renal Cell Carcinoma (2012) (59)
Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. (2005) (58)
Primary Mediastinal Seminoma: A Comprehensive Assessment Integrated With Histology, Immunohistochemistry, and Fluorescence In Situ Hybridization for Chromosome 12p Abnormalities in 23 Cases (2008) (58)
Ureteral endometriosis: clinicopathological and immunohistochemical study of 7 cases. (2008) (58)
Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer. (2008) (57)
Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. (2000) (55)
High‐fat diet activates pro‐inflammatory response in the prostate through association of Stat‐3 and NF‐κB (2012) (53)
PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline. (2009) (51)
Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma (2015) (51)
Ectopic prostatic tissue: histogenesis and histopathological characteristics (2011) (50)
Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change (2016) (48)
Molecular determinants of tumor recurrence in the urinary bladder. (2009) (48)
Small Cell Carcinoma of the Urinary Bladder—Histogenesis, Genetics, Diagnosis, Biomarkers, Treatment, and Prognosis (2007) (47)
Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art. (2010) (47)
Primary renal lymphoma: a rare neoplasm that may present as a primary renal mass. (2005) (46)
Renal pseudotumors. (2007) (46)
Deregulation of FoxO3a accelerates prostate cancer progression in TRAMP mice (2013) (46)
Germ Cell Origin of Testicular Carcinoid Tumors (2008) (45)
IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients. (2011) (45)
The landscape of EGFR pathways and personalized management of non-small-cell lung cancer. (2011) (45)
Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry. (2013) (44)
Primary Ewing sarcoma/primitive neuroectodermal tumor of the kidney. (2009) (44)
Update on fused capromab pendetide imaging of prostate cancer. (2005) (44)
Multilocular cystic renal cell carcinoma. (2007) (43)
Perfusion-modulated MR imaging-guided radiofrequency ablation of the kidney in a porcine model. (2001) (43)
Inflammatory Signaling Involved in High-Fat Diet Induced Prostate Diseases. (2015) (42)
Retroperitoneal liposarcoma. (2007) (42)
Polymorphisms in Polycyclic Aromatic Hydrocarbon Metabolism and Conjugation Genes, Interactions with Smoking and Prostate Cancer Risk (2006) (41)
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists. (2014) (40)
Upregulation of SATB1 Is Associated with Prostate Cancer Aggressiveness and Disease Progression (2013) (40)
Evidence for Polyclonal Origin of Multifocal Clear Cell Renal Cell Carcinoma (2008) (40)
Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation. (2019) (39)
Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management (2011) (39)
FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations (2009) (38)
Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model (2012) (37)
Prostate cancer and other xenografts from cells in peripheral blood of patients. (2000) (37)
Radiation cystitis. (2009) (36)
Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults. (2013) (36)
Prostatic stromal hyperplasia with atypia: follow-up study of 18 cases. (2009) (36)
The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma. (2002) (36)
Oxidative Stress and Antioxidant Status in High-Risk Prostate Cancer Subjects (2013) (36)
Evidence for Transformation of Fibroadenoma of the Breast to Malignant Phyllodes Tumor (2009) (36)
Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: A fluorescence in situ hybridization and immunohistochemical analysis (2008) (36)
Association between periodontal disease and prostate-specific antigen levels in chronic prostatitis patients. (2010) (35)
Renal pseudotumors. (2005) (35)
α-methylacyl-CoA racemase (P504S)/34βE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy (2007) (34)
Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy (2010) (34)
Benign neoplasms of the epididymis. (2005) (34)
Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder (2008) (34)
Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization. (2009) (34)
Diagnostic Accuracy of a Rapid Biparametric MRI Protocol for Detection of Histologically Proven Prostate Cancer. (2018) (33)
Follicular large cell lymphoma localized to the testis in children. (2002) (33)
High-grade transitional cell carcinoma and melanosis of urinary bladder: case report and review of the literature. (2009) (32)
Leiomyoma of the urethra and bladder. (2007) (32)
Il‐1β‐induced post‐transition effect of NF‐kappaB provides time‐dependent wave of signals for initial phase of intrapostatic inflammation (2009) (31)
Embolic testicular infarction secondary to nonbacterial thrombotic endocarditis in Wegener's granulomatosis. (1999) (31)
Bladder amyloidosis. (2010) (31)
Basal cell carcinoma of the prostate is an aggressive tumor with frequent loss of PTEN expression and overexpression of EGFR. (2015) (30)
Molecular imaging of NF‐kappaB in prostate tissue after systemic administration of IL‐1β (2008) (30)
Increased androgen receptor gene copy number is associated with TMPRSS2‐ERG rearrangement in prostatic small cell carcinoma (2015) (29)
Allelic loss of the active X chromosome during bladder carcinogenesis. (2004) (29)
Quantitative Evaluation of 2-Deoxy-2[F-18]fluoro-d-glucose-Positron Emission Tomography Imaging on the Woodchuck Model of Hepatocellular Carcinoma with Histological Correlation (2007) (29)
Leiomyosarcoma of the prostate. (2007) (28)
The clinical and therapeutic implications of cancer stem cell biology (2011) (28)
Is atypical adenomatous hyperplasia of the prostate a precursor lesion? (2011) (27)
Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma. (2017) (27)
Soft tissue tumors of the penis: a review. (2006) (27)
Mucinous tubular and spindle cell carcinoma of the kidney. (2010) (27)
Endoscopic snare resection of bladder tumors: evaluation of an alternative technique for bladder tumor resection. (2012) (26)
P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. (2005) (26)
Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma (2009) (26)
Adenoid cystic/basal cell carcinoma of the prostate. (2008) (25)
P2X7 receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin (2009) (25)
Screening for Intratubular Germ Cell Neoplasia of the Testis Using OCT4 Immunohistochemistry (2006) (24)
Cystic partially regressed clear cell renal cell carcinoma: a potential mimic of multilocular cystic renal cell carcinoma (2013) (24)
Paratesticular liposarcoma. (2009) (24)
Cyclin E as molecular marker in the management of breast cancer: a review. (2006) (24)
Lymphatic vessel density in radical prostatectomy specimens. (2008) (24)
Image‐guided biopsy of small renal masses in the era of ablative therapies (2013) (23)
Fluorescence in situ hybridization in surgical pathology: principles and applications (2017) (23)
Transitional cell carcinoma recurrence in the nephrostomy tract after percutaneous resection. (2003) (22)
Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. (2019) (22)
Human Papillomavirus is Not an Etiologic Agent of Urothelial Inverted Papillomas (2013) (22)
Penis and male urethra (2012) (22)
Retroperitoneal Seminoma in Limited Biopsies: Morphologic Criteria and Immunohistochemical Findings in 30 Cases (2006) (21)
Prostatic leiomyoma with atypia: follow-up study of 10 cases. (2008) (21)
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation (2016) (21)
Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis. (2004) (21)
TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract. (2017) (21)
Research advances in apoptosis-mediated cancer therapy: a review. (2007) (21)
Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure. (2000) (20)
Unusual female suburethral mass lesions. (2005) (20)
KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas (2012) (20)
Primary melanoma of the bladder. (2011) (19)
Atypical Adenomatous Hyperplasia of Prostate Lacks TMPRSS2-ERG Gene Fusion (2013) (19)
Carcinoid tumor of the kidney. (2008) (19)
Benign soft tissue tumors of the testis. (2009) (18)
Three-dimensional imaging of ureter with endoscopic optical coherence tomography. (2011) (18)
Vasitis and epididymitis nodosa. (2006) (18)
Obesity‐initiated metabolic syndrome promotes urinary voiding dysfunction in a mouse model (2016) (18)
Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis (2006) (17)
Rhabdomyosarcoma of the bladder and prostate. (2005) (17)
Photodynamic Therapy is an Effective Adjuvant Therapy for Image-Guided Surgery in Prostate Cancer. (2019) (17)
Sarcoidosis of the testis and epididymis. (2008) (16)
Clear cell adenocarcinoma of the bladder and urethra. (2008) (16)
Rare (<1%) histological subtypes of renal cell carcinoma: an update (2012) (16)
Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in‐situ hybridization for the detection of anaplastic lymphoma kinase alterations (2015) (16)
T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning–derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology (2020) (16)
Androgen Deprivation Induces Transcriptional Reprogramming in Prostate Cancer Cells to Develop Stem Cell-Like Characteristics (2020) (16)
Leydig cell tumor of the testis. (2009) (16)
Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy. (2007) (16)
Ganglioneuroma of the adrenal gland. (2009) (16)
Tumors of the male urethra. (2005) (15)
Mixed epithelial and stromal tumor of the kidney. (2009) (15)
Multimodal and three-dimensional imaging of prostate cancer. (2005) (15)
Periodontal Treatment Improves Prostate Symptoms and Lowers Serum PSA in Men with High PSA and Chronic Periodontitis (2015) (15)
Failure to detect the presence of prions in the uterine and gestational tissues from a Gravida with Creutzfeldt-Jakob disease. (2009) (15)
Renal neoplasms. (1987) (15)
Granular necrosis: a distinctive form of cell death in malignant tumours. (2020) (15)
Five decades of urologic pathology: the accelerating expansion of knowledge in renal cell neoplasia. (2019) (15)
Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens (2017) (15)
Anatomic, morphologic and genetic heterogeneity of prostate cancer: implications for clinical practice (2012) (14)
Testicular plasmacytoma. (2020) (14)
Adrenal adenomatoid tumor in a patient with human immunodeficiency virus (2011) (14)
Miniature forward-viewing common-path OCT probe for imaging the renal pelvis. (2015) (14)
Immunohistochemical distinction of metastases of renal cell carcinoma to the adrenal from primary adrenal nodules, including oncocytic tumor (2015) (14)
Sarcomatoid urothelial carcinoma of the renal pelvis. (2006) (14)
Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer. (2009) (14)
Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the NAB2-STAT6 fusion gene (2016) (14)
Xanthogranulomatous Sialadenitis: A Case Report and Literature Review (2005) (14)
Evidence for clonal fibroblast proliferation and autoimmune process in idiopathic retroperitoneal fibrosis. (2012) (14)
The applicability and utility of immunohistochemical biomarkers in bladder pathology. (2020) (14)
Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma. (2020) (13)
Hemoptysis as an unusual presenting symptom of invasion of a descending thoracic aortic aneurysmal dissection by lung cancer. (2002) (13)
Urine cytology in the evaluation of upper tract urothelial lesions. (2004) (13)
Large cell calcifying Sertoli cell tumor of testis. (2007) (13)
Is trigonitis a neglected, imprecise, misunderstood, or forgotten diagnosis? (2019) (12)
Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of BRAF mutations. (2013) (12)
Pathology for Urologists (2003) (12)
Evaluating the impact of the genitourinary multidisciplinary tumour board: Should every cancer patient be discussed as standard of care? (2018) (12)
Distinct mutational landscape of inverted urothelial papilloma (2019) (11)
Multiscale fuzzy C-means image classification for multiple weighted MR images for the assessment of photodynamic therapy in mice (2007) (11)
Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer (2020) (11)
Small cell carcinoma of the prostate: molecular basis and clinical implications. (2015) (11)
Epidermoid cyst of the testis. (2008) (11)
Squamous cell carcinoma of the renal pelvis. (2010) (11)
Paraganglioma of the prostate. (2006) (10)
EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder (2014) (10)
Penis and Scrotum (2010) (10)
Solitary fibrous tumor of the kidney. (2009) (10)
Renal cell carcinoma metastasis to the bladder. (2010) (10)
Abdominoperineal resection. Treatment of choice for carcinoma of the rectum (1976) (10)
Extramammary Paget's disease of the penis and scrotum. (2009) (10)
Splenogonadal fusion. (2010) (9)
Adenomatoid tumor of the adrenal gland. (2008) (9)
Mesothelioma of the tunica vaginalis. (2007) (9)
Atlas of Genitourinary Pathology (2010) (9)
Testicular juvenile capillary hemangioma: conservative management with frozen-section examination. A case report. (1994) (9)
Phyllodes tumor of the prostate. (2005) (9)
Renal cell carcinoma and other concurrent renal neoplasms. (2007) (9)
Renal cell carcinoma associated with end stage renal disease. (2006) (9)
Primary testicular lymphoma. (2007) (9)
Gender Disparities in Bladder Cancer Specific Survival in High Poverty Areas Utilizing Ohio Cancer Incidence Surveillance System (OCISS). (2020) (8)
Translocation carcinoma of the kidney. (2008) (8)
Aggressive angiomyxoma of the male genital region. (2008) (8)
Congenital mesoblastic nephroma. (2010) (8)
Neoplasms of the Kidney (2016) (8)
Tubulocystic carcinoma of the kidney. (2011) (8)
Melanosis of the bladder. (2011) (8)
Spontaneous metastasis in mouse models of testicular germ-cell tumours. (2011) (8)
Differentially Expressed Genes and Molecular Pathways in an Autochthonous Mouse Prostate Cancer Model (2019) (7)
Intestinal metaplasia of the bladder. (2006) (7)
Clear cell sarcoma of the kidney. (2011) (7)
Eosinophilic metaplasia of the prostate: a newly described lesion distinct from other eosinophilic changes in prostatic epithelium. (2008) (7)
Nephrogenic adenoma of the bladder. (2010) (7)
Pathology pageSpermatocytic Seminoma (2007) (6)
Endometriosis of the ureter. (2008) (6)
US case of the day. Right epididymo-orchitis due to disseminated Blastomyces dermatitidis. (1994) (6)
Molecular imaging of nuclear factor-κB in bladder as a primary regulator of inflammatory response. (2012) (6)
Whole mount histopathological correlation with prostate MRI in Grade I and II prostatectomy patients (2019) (6)
Benign vascular lesions of the scrotum. (2006) (6)
Juxtaglomerular cell tumor of the kidney. (2006) (6)
Giant intrathyroid parathyroid adenoma: a preoperative and intraoperative diagnostic challenge. (2009) (6)
Fibrous pseudotumor of the tunica vaginalis. (2008) (6)
Renal Pelvis and Ureter (2020) (5)
TMPRSS2‐ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer (2016) (5)
"Burnt-out" testicular germ cell tumors. (2005) (5)
Simulation of Microcalcifications on Specimen Radiographs of Breast Biopsies by Inks Used in Marking the Surgical Resection Margins (2004) (5)
Laser capture microdissection in molecular diagnostics (2014) (5)
Immunohistochemical markers in the diagnosis of prostate cancer. (2005) (5)
Intraductal carcinoma of the prostate is not a diagnostic entity (2020) (5)
Testicular Adnexal Smooth Muscle Hyperplasia: A Mimic of Malignancy. (2015) (4)
Genetic Abnormalities in Prostate Cancer (2004) (4)
Extravesical Pagetoid Spread of Urothelial Carcinoma in Situ. A Report of Five Cases. (2015) (4)
Choline molecular imaging with small-animal PET for monitoring tumor cellular response to photodynamic therapy of cancer (2009) (4)
Mesodermal adenosarcoma of the testis. (2005) (4)
Presence of Specific Periodontal Pathogens in Prostate Gland Diagnosed With Chronic Inflammation and Adenocarcinoma (2021) (4)
Small cell carcinoma of the bladder. (2006) (4)
Genitourinary radiology: Kidney, bladder and urethra the pathologic basis (2013) (4)
Paratesticular rhabdomyosarcoma. (2009) (4)
Deregulation of FOXO 3 A during prostate cancer progression (4)
Kidney, ureter, and adrenal glands (2012) (4)
Comprar Hinman's Atlas of UroSurgical Anatomy, 2nd Edition | Greg MacLennan | 9781416040897 | Saunders (2012) (4)
Urinary tract schistosomiasis. (2010) (3)
Identification of Key Genes Associated with Progression and Prognosis of Bladder Cancer through Integrated Bioinformatics Analysis (2021) (3)
Bilateral acquired cystic kidney associated renal cell carcinoma with sarcomatoid features – A rare entity (2018) (3)
Cystic partially differentiated nephroblastoma. (2010) (3)
Neoplasms of the Prostate and Seminal Vesicles (2013) (3)
Early Bone Metastases are Associated with Worse Outcomes in Metastatic Urothelial Carcinoma (2021) (3)
Maspin Expression and its Metastasis Suppressing Function in Prostate Cancer (2016) (3)
Renal medullary carcinoma. (2005) (3)
Neoplasms of the Urinary Bladder (2020) (3)
The trigger-maintenance model of persistent mild to moderate hyperoxaluria induces oxalate accumulation in non-renal tissues (2013) (3)
Abstract 5452: High-fat diet induces inflammation by increasing estrogen levels through Stat3, estrogen receptor alpha and aromatase in the mouse prostate. (2013) (3)
Liposarcoma presenting as a pulmonary embolism with right-sided cardiac strain (2017) (2)
107: Does Chronic Inflammation Influence Prostate Carcinogenesis? A Five Year Follow-Up Study (2006) (2)
Atypical Small Acinar Proliferation of the Prostate Gland (1998) (2)
Prostate and urethral sphincters (2012) (2)
Small cell carcinoma of the prostate. (2009) (2)
"Robotic fatigue?" - The impact of case order on positive surgical margins in robotic-assisted laparoscopic prostatectomy. (2020) (2)
Expression of the Macrophage-Associated Antigen CD68/KP1 by Tumor Cells of Sarcomatoid Renal Cell Carcinoma (1999) (2)
Spermatocytic seminoma. (2007) (2)
The Role of Chronic Inflammation in Prostate Carcinogenesis: A Follow-Up Study (2019) (2)
Benign cystic lesions of the rete testes. (2006) (2)
Pathology of flat bladder lesions with emphasis on putative precursors (2013) (2)
Pathology–Endoscopy Correlations of Bladder, Urachal, and Urethral Lesions (2012) (2)
804 IL-17 EXPRESSED LEUKOCYTES ARE CHARACTERISTIC OF PROSTATE INFLAMMATORY ATROPHY LESIONS IN PATIENTS WITH PROSTATE CANCER (2010) (2)
Neural neoplasms of the bladder. (2010) (2)
Renal epithelioid angiomyolipoma. (2009) (2)
Sarcomatoid Chromophobe Renal Cell Carcinoma: Report of an Additional Case with Ultrastructural Findings (1999) (2)
Development of a novel castration‐resistant orthotopic prostate cancer model in New Zealand White rabbit (2022) (2)
Constitutive activation of PI3K-Akt and NF-κB signaling pathway in transgenic adenocarcinoma of the mouse prostate model (2005) (2)
Focal Prostate Stereotactic Body Radiation Therapy With Correlative Pathological and Radiographic-Based Treatment Planning (2021) (2)
Female genital tract and urethra (2012) (2)
2232 INCREASED OXIDATIVE STRESS AND DNA DAMAGE IN HIGH-RISK PROSTATE CANCER SUBJECTS (2013) (1)
Wilms tumor. (2005) (1)
Congenital and Acquired Nonneoplastic Disorders of the Penis and Scrotum (2013) (1)
Neoplasms of the Bladder (2013) (1)
Erratum to: Trials of new germ cell immunohistochemical stains in 93 extragonadal and metastatic germ cell tumors” [Human Pathology 2008;39:275-281] (2013) (1)
Nongerm cell malignancies in testicular germ cell tumors. (2010) (1)
Congenital and Acquired Nonneoplastic Adrenal Diseases (2013) (1)
Adrenal hemorrhage. (2007) (1)
ATYPICAL SMALL ACINAR PROLIFERATIONS. AUTHORS' REPLY (1999) (1)
MP62-09 CLASS I HDAC INHIBITION AND P53 ACTIVATION UPREGULATES MASPIN IN HUMAN PROSTATE CANCER (2016) (1)
Müllerian lesions of the bladder. (2004) (1)
Cystic Diseases of the Kidney (2013) (1)
Racial disparities in biochemical recurrence of prostate cancer. (2022) (1)
Characterization and functional analysis of microbiome in bladder cancer. (2022) (1)
Vascular disorders of the kidney (2013) (1)
Posterolateral and posterior body wall (2012) (1)
Neoplasms of the Renal Pelvis and Ureter (2013) (1)
Neoplasms of the Spermatic Cord and Testicular Adnexae (2013) (1)
Nuclear factor-kappaB provides mechanistic link between inflammation and prostate cancer (2009) (1)
Congenital and Acquired Nonneoplastic Disorders of the Spermatic Cord and Testicular Adnexae (2013) (1)
Atypical Small Acinar Proliferations (1999) (1)
Genitourinary radiology: Male genital tract, adrenal and retroperitoneum: The pathologic basis (2013) (1)
Adrenocortical carcinoma. (2008) (1)
A preliminary evaluation of in vivo response to a filament-wound macroporous collagen midurethral sling in an ovine model. (2022) (1)
Some pitfalls in pathological staging of invasive urothelial carcinoma. (2004) (1)
MP35-09 COMBINATION OF NF-κB/P65 NUCLEAR LOCALIZATION AND GLAND MORPHOLOGIC FEATURES IS PREDICTIVE OF BIOCHEMICAL RECURRENCE (2018) (1)
MP17-03 A MINIATURE FORWARD-VIEWING ENDOSCOPIC OPTICAL COHERENCE TOMOGRAPHY PROBE FOR RENAL PELVIC IMAGING (2015) (0)
ROLE OF CHRONIC INFLAMMATION IN PROSTATE CANCER: A STUDY ON NEEDLE BIOPSY SPECIMENS: MP11‐01 (2017) (0)
DEREGULATION OF FOXO3A CONTRIBUTES TO PROSTATE CANCER PROGRESSION (2008) (0)
Small Molecule Therapeutics Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer (2014) (0)
FINASTERIDE INDUCES HYPOXIA-INDUCIBLE FACTOR 1-ALPHA IN THE PROSTATE OF SPRAGUE-DAWLEY RATS (2009) (0)
Abstract 1080: Targeting the PI3K-Akt and NF-κB pathways as a combination therapy in blocking prostate cancer progression (2017) (0)
404: Chronic Inflammation-Induced Cell Survival and Proliferation in Pre-Malignant Lesions and Incidental Prostate Carcinoma: A Needle Biopsy Study (2004) (0)
MP49-08 PROGNOSTIC SIGNIFICANCE OF DEPTH OF INVASION IN TRANSURETHRAL RESECTION OF BLADDER TUMOR SPECIMENS. (2016) (0)
PD27-06 SIMVASTATIN AND METFORMIN: A DEADLY COMBINATION FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2014) (0)
Myofibroblastic proliferations of the bladder. (2007) (0)
Abstract 4347: Differentially expressed genes and molecular pathways in an autochthonous mouse prostate cancer model (2019) (0)
Adrenal cortical neoplasms: Perspectives in pediatric patients (2015) (0)
Peripheral nervous system (2012) (0)
Inflammatory Conditions of the Kidney (2013) (0)
Renal Neoplasms: An Ever-changing Landscape (2005) (0)
MP46-04 REAL TIME IN VIVO MOLECULAR IMAGING OF NF-κB IN PROSTATE CANCER: ROLE AS PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET (2015) (0)
110: Intra-Prostate Cell Phenotyping: A Predominance of NK, NKT Cells and Upregulation of CD45RC and CD161A in CD4+ T Cells (2004) (0)
Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model (2011) (0)
Abstract 91: NF-κB as a prognostic marker and therapeutic target in prostate cancer (2015) (0)
Penis and Scrotum Pathology (2020) (0)
Cytokeratin (AE1/AE3) in addition to α-methylacyl coenzyme A racemase (P504S), 34-beta-E12,and p63 stains in evaluation of surgical specimens after hormonal therapy for prostatic adenocarcinoma-reply (2008) (0)
HISTONE DEACETYLASE (HDAC1) AND HISTONE ACETYLTRANSFERASE (CBP/P300) IN THE PATHOGENESIS OF PROSTATE CANCER (2009) (0)
Congenital and Acquired Nonneoplastic Retroperitoneal Disorders (2013) (0)
MP56-10 CHARACTERIZATION AND FUNCTIONAL ANALYSIS OF MICROBIOME IN BLADDER CANCER (2022) (0)
CHEMOATTRACTANT SIGNALS PROVIDE RELATIONSHIP BETWEEN NUCLEAR FACTOR-kappaB AND INTRAPROSTATIC INFLAMMATION (2008) (0)
Spermatic Cord and Testicular Adnexae (2010) (0)
Abstract 4097: Enhanced synergistic efficacy of simvastatin and metformin on enzalutamide resistant prostate cancer cells (2020) (0)
Abstract LB-021: Combination of quantitative histomorphometry with NFκB/p65 nuclear localization is better predictor of biochemical recurrence in prostate cancer patients (2018) (0)
Congenital and Acquired Nonneoplastic Disorders of the Prostate and Seminal Vesicles (2013) (0)
Medical Renal Disease and Transplantation Considerations (2013) (0)
Correction to: T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning–derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology (2020) (0)
Neoplasms of the Penis and Scrotum (2013) (0)
Comprar Atlas of Genitourinary Pathology | Cheng, Liang | 9781848823945 | Springer (2010) (0)
Outcomes in bone predominant (BP) urothelial carcinoma (UC). (2018) (0)
Neoplasms of the Testis (2013) (0)
Patterns of metastases, treatment (tx), and outcomes in bone predominant (BP) metastatic urothelial carcinoma (mUC). (2018) (0)
Bladder, ureterovesical junction, and rectum (2012) (0)
Frequent Telomerase Reverse Transcriptase (TERT) Promoter and Fibroblast Growth Factor Receptor 3 (FGFR3) Mutations Support the Precursor Nature of Papillary Urothelial Hyperplasia of the Urinary Bladder. (2023) (0)
GATA3 expression in clear cell adenocarcinoma of the lower urinary tract: a potential diagnostic pitfall (2022) (0)
MP79-03 DRUG REPURPOSING APPROACH FOR DEVELOPING NOVEL THERAPY FOR CASTRATION RESISTANT PROSTATE CANCER (2020) (0)
Abstract LB-255: Prognostic role of neuroendocrine differentiation marker in prostate adenocarcinoma (2017) (0)
Ser‐486/491 phosphorylation and inhibition of AMPKα activity is positively associated with Gleason score, metastasis, and castration‐resistance in prostate cancer: A retrospective clinical study (2018) (0)
Preface to the Fourth Edition (2020) (0)
Molecular Imaging of Nuclear Factor-kappaB in Urinary Bladder as a Primary Regulator of Inflammatory Response (2013) (0)
Abstract 5168: Assessment and prognostic implication of 3-gene signature identified as potential biomarker in bladder cancer (2022) (0)
HIGH-FAT DIET CAUSES IMMUNE SUPPRESSION AND INCREASED INFLAMMATION IN MPAKT MICE (2009) (0)
Congenital and Acquired Nonneoplastic Disorders of the Urethra (2013) (0)
Neoplasms of the Urethra (2013) (0)
Activation of PI3K-Akt signaling pathway leads to prostate cancer progression (2005) (0)
Tumors of the Urinary Bladder (2013) (0)
Bladder, Urethra, and Urachus (2010) (0)
Comparison of Morphological and Histological Characteristics of Human and Sheep: Sheep as a Potential Model for Testing Midurethral Slings in vivo. (2022) (0)
In fl ammatory Conditions of the Kidney (2018) (0)
Abstract 2364: Overexpression of SATB1 (Special AT-Rich Sequence-Binding Protein 1) in prostate cancer potentiates metastatic phenotype (2010) (0)
Abstract 492: Chronic inflammation contributes to neoplastic progression in prostate tissue: a needle biopsy study (2017) (0)
C-Ret Proto-Oncogene Expression in Human Prostate: An Immunohistochemical Evaluation (1997) (0)
Comment on: Renal Metanephric Adenoma. Authors' reply (2008) (0)
Prostate Cancer and Other Xenografts from Cells in Peripheral Blood of Patients 1 (2000) (0)
Abstract 5084: Epigenetic modifications involving reactivation of RECK inhibiting MMP-9 and MMP-2 in prostate cancer (2019) (0)
Abstract 4963: A distinct AMP-activated protein kinase phosphorylation site is associated with metastasis and castration-resistance in prostate cancer (2016) (0)
412: Increased Phospho-AKT Overrides Androgen Receptor Signaling in MPAKT Mice (2006) (0)
MP72-02 RE-EXAMINING THE DEPTH OF INVASION IN HIGH-GRADE T1 BLADDER CANCER AND CLINICAL OUTCOMES:AN INDEPENDENT PREDICTOR OF SURVIVAL (2020) (0)
Influence of chronic inflammation on prostate carcinogenesis: A five year follow-up study (2006) (0)
Emerging clinical phenotype of bone metastatic urothelial cancer (mUC): Association of early osseous metastases (EOM) and outcomes. (2020) (0)
PD10-09 IDENTIFICATION OF A 3-GENE PANEL IN THE PREDICTION AND PROGNOSIS OF BLADDER CANCER (2022) (0)
THE ROLE OF CHRONIC PROSTATIC INFLAMMATION IN PROSTATE CARCINOGENESIS: A RETROSPECTIVE FOLLOW‐UP STUDY: MP33‐14 (2017) (0)
Pathology Page UNUSUAL FEMALE SUBURETHRAL MASS LESIONS (2005) (0)
Abstract 655: Racial difference in CXC motif chemokine receptor 4 expression in prostate cancer (2021) (0)
Short Communication Failure to Detect the Presence of Prions in the Uterine and Gestational Tissues from a Gravida with Creutzfeldt-Jakob Disease (2009) (0)
PD32-10 PHOSPHORYLATION OF AMPKα AT SER-485/491 IS ASSOCIATED WITH METASTASIS AND CASTRATION-RESISTANCE IN PROSTATE CANCER: A CLINICAL STUDY (2016) (0)
Abstract C088: Biological and neighborhood-level social determinants of prostate disease aggressiveness among Black and White men undergoing prostate biopsy (2023) (0)
MP08-16 COMBINATION OF NUCLEAR ORIENTATION AND SHAPE FEATURES IN H&E STAINED IMAGES DISTINGUISH CONSENSUS LOW AND HIGH GRADE BLADDER CANCER (2018) (0)
Differential E xpression o f S 100A2 a nd S 100A4 D uring Progression o f H uman P rostate A denocarcinoma (2003) (0)
1179 HIGH-FAT DIET INDUCED INFLAMMATION IN THE PROSTATE: ROLE OF STAT-3, ER-ALPHA AND AROMATASE (2013) (0)
PD43-02 THE IMPACT OF CASE ORDER ON POSITIVE SURGICAL MARGINS FOR PROSTATE CANCER: A MULTI-INSTITUTIONAL ANALYSIS (2020) (0)
Mice Apigenin Suppresses Prostate Carcinogenesis in TRAMP-Catenin Signaling by Plant Flavonoid β Blockade of Updated (2007) (0)
Immunological and molecular studies in kidney tumors (2012) (0)
Nuclear factor-kappaB provides mechanistic link between inflammation and prostate cancer (93.8) (2009) (0)
Non-neoplastic Disorders of the Renal Pelvis and Ureter (2013) (0)
774 TRANSGASTRIC NOTESTM PARTIAL CYSTECTOMY: A PROSPECTIVE CHRONIC PORCINE STUDY (2011) (0)
PROSTATE CANCER AGGRESSIVENESS IS MEDIATED BY AKT AND NF‐&kgr;B SIGNALING PATHWAYS: A SYSTEMS BIOLOGY APPROACH: PD33‐02 (2017) (0)
Rare tumors of the adrenal gland (2015) (0)
Abstract 617: Apigenin intake regulates Fox ‘O’ signaling in an autochthonous mouse model of prostate cancer (2012) (0)
LOSS OF MASPIN EXPRESSION IS A POTENTIAL PROGNOSTIC FACTOR DURING PROSTATE CANCER PROGRESSION (2008) (0)
Tumors of the Kidney (2011) (0)
Nonneoplastic Disorders of the Bladder (2013) (0)
Association of early bone metastases and outcomes of the bone predominant metastatic urothelial carcinoma (BP mUC) phenotype. (2019) (0)
Anterolateral body wall (2012) (0)
"IDENTIFICATION OF AGES AND AGE-RECEPTOR IN HUMAN PENIS" (1999) (0)
92: Possible Role of Nuclear Factor-Kappab in Intraprostatic Inflammation (2007) (0)

This paper list is powered by the following services:

Gregory T. Maclennan's Academic­Influence.com Rankings

Why Is Gregory T. Maclennan Influential?

Gregory T. Maclennan's Published Works

Published Works

Gregory T. Maclennan's AcademicInfluence.com Rankings